VC-Style* Research for Public Markets: built by a multidisciplinary team focused on identifying companies across public and private markets through our proprietary VC Lens framework.
Built on 30+ years of research from Babson College & Harvard University.
VC Lens methodology applied with institutional rigor across every allocation decision within public markets.
Operating standards built for advisors, allocators, and individual investors alike.
Each member brings a distinct lens to private and public market investing, drawn from research, capital markets, and operating roles.
Dr. Joel Shulman is the CEO and CIO of ERShares. He is the architect of the Entrepreneur Factor® and ERShares’ VC lens investment framework, which applies venture-style research principles to publicly traded companies.
Eva Ados is Chief Investment Strategist and Chief Operating Officer at ERShares, where she helps shape the firm’s macro views, thematic research priorities, and operations.
Kevin Cramton is Director of Private Equity at ERShares, where he focuses on private-market research, evaluation, and due diligence related to private-company exposure.
Mihai Prisacariu is Senior Vice President of Operations and Compliance at ERShares. He supports compliance policies, risk management, regulatory oversight, ETF market research, investment structuring, and operational processes. He has been involved with ERShares’ regulatory and operational functions since 2017.
Rahul Raj is a Senior Financial Analyst at ERShares, focused on portfolio management support, financial analysis, and research across ETFs, mutual funds, and index strategies.
Original analysis and fund updates from the ERShares team. Or reach out directly to discuss XOVR, ENTIX, or how the VC Lens methodology applies to your portfolio.
ERShares funds are available through most major brokerage platforms. Buy XOVR and ENTIX directly in your existing account.
We are sharing an update on XOVR's SpaceX exposure, performance, and four stages of innovation during the SpaceX IPO period.
From March 30 through June 15, 2026, XOVR's SpaceX exposure reflected more than $183 million of unrealized appreciation, including appreciation associated with SpaceX's IPO and commencement of public trading on NASDAQ on June 12, 2026.
Over the same period, XOVR appreciated approximately 30.71%, with SpaceX exposure contributing significantly to ETF performance.
The update also highlights four XOVR innovations: the private-public crossover ETF structure, the 0/0 SPV structure, a first-of-its-kind liquidity arrangement, and the Shareholder Protection Plan designed to prioritize existing long-term shareholders during the SpaceX IPO period.
Subscribe to our newsletter to stay updated about the global markets.
